Your session is about to expire
← Back to Search
probiotic plus prebiotic supplement for Generalized Anxiety Disorder (ABBCS Trial)
N/A
Waitlist Available
Led By Andrew D Frugé, PhD
Research Sponsored by Auburn University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
ABBCS Trial Summary
Anti-anxiety Biotics for Breast Cancer Survivors
Eligible Conditions
- Generalized Anxiety Disorder
- Breast Cancer
ABBCS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility - Accrual
Feasibility - Adherence
Feasibility - Retention
Secondary outcome measures
Anxiety Symptoms
Fecal Microbiome Composition
Inflammatory Marker - IL-6
+3 moreABBCS Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Synbiotic supplement groupExperimental Treatment1 Intervention
Daily consumption of pills containing prebiotics and probiotics
Group II: Placebo groupPlacebo Group1 Intervention
Daily consumption of pills containing maltodextrin
Find a Location
Who is running the clinical trial?
National Center for Advancing Translational Sciences (NCATS)NIH
320 Previous Clinical Trials
401,727 Total Patients Enrolled
Auburn UniversityLead Sponsor
72 Previous Clinical Trials
14,402 Total Patients Enrolled
University of Alabama at Birmingham - Center for Clinical and Translational ScienceUNKNOWN
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger